Eosinophilic Fasciitis: Current and Remaining Challenges.
Mazilu D, Boltașiu Tătaru LA, Mardale DA, Bijă MS, Ismail S, Zanfir V, Negoi F, Balanescu AR.
Int J Mol Sci. 2023 Jan 19;24(3):1982. doi: 10.3390/ijms24031982.
Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
Ferreli C, Gasparini G, Parodi A, Cozzani E, Rongioletti F, Atzori L.
Clin Rev Allergy Immunol. 2017 Dec;53(3):306-336. doi: 10.1007/s12016-017-8625-4.
Scleroderma-like Disorders.
Sharma A.
Curr Rheumatol Rev. 2018 Apr 20;14(1):22-27. doi: 10.2174/1573397113666170612091419.
[Sclerosing skin diseases].
Sticherling M.
Internist (Berl). 2019 Aug;60(8):783-791. doi: 10.1007/s00108-019-0643-2.
Scleroderma Mimickers.
Morgan ND, Hummers LK.
Curr Treatm Opt Rheumatol. 2016 Mar;2(1):69-84. doi: 10.1007/s40674-016-0038-7. Epub 2016 Feb 5.
[Eosinophilic fasciitis].
Niklas K, Niklas A, Puszczewicz M.
Postepy Hig Med Dosw (Online). 2015 Jan 2;69:488-95. doi: 10.5604/17322693.1149872.
Controversy around the morphea.
Dańczak-Pazdrowska A, Cieplewicz P, Żaba R, Adamski Z, Polańska A.
Postepy Dermatol Alergol. 2021 Oct;38(5):716-720. doi: 10.5114/ada.2021.106242. Epub 2021 May 18.
Immunologic and nonimmunologic sclerodermal skin conditions - review.
Bobeica C, Niculet E, Craescu M, Parapiru EL, Corduneanu-Luca AM, Debita M, Pelin AM, Tiutiuca C, Vasile CI, Nicolescu AC, Miulescu M, Balan G, Tatu AL.
Front Immunol. 2023 Jul 12;14:1180221. doi: 10.3389/fimmu.2023.1180221. eCollection 2023.
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019.
GBD 2019 IMID Collaborators.
EClinicalMedicine. 2023 Sep 9;64:102193. doi: 10.1016/j.eclinm.2023.102193. eCollection 2023 Oct.
Scleroderma-like fibrosing disorders.
Boin F, Hummers LK.
Rheum Dis Clin North Am. 2008 Feb;34(1):199-220; ix. doi: 10.1016/j.rdc.2007.11.001.
